• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].
 

Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].

Options
  • Details
  • Files
BORIS DOI
10.48350/179930
Publisher DOI
10.1016/j.eururo.2023.03.002
PubMed ID
36907692
Date of Publication
2023-06
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Language(s)
en
Contributor(s)
Gil-Jimenez, Alberto
van Dorp, Jeroen
Contreras-Sanz, Alberto
van der Vos, Kristan
Vis, Daniel J
Braaf, Linde
Broeks, Annegien
Kerkhoven, Ron
van Kessel, Kim E M
Ribal, María José
Alcaraz, Antonio
Wessels, Lodewyk F A
Seiler-Blarer, Roland
Department for BioMedical Research, Forschungsgruppe Urologie
Wright, Jonathan L
Mengual, Lourdes
Boormans, Joost
van Rhijn, Bas W G
Black, Peter C
van der Heijden, Michiel S
Additional Credits
Department for BioMedical Research, Forschungsgruppe Urologie
Series
European urology
Publisher
Elsevier
ISSN
1873-7560
Related URL(s)
https://boris.unibe.ch/172047/
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo